Stem cell shots: Unveiling a safer way to treat inflammatory eye diseases

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor’s immune cells attack the recipient’s tissues. Ocular manifestation of GVHD is among the most challenging to treat, often leading to chronic inflammation and corneal tissue damage, which can result in loss of vision.